(AAA) repair identified the shortcomings of the current risk calculators. Those were the sole reliance on the physiologic condition of the patient and lack of aneurysm-related predictors. For example, the Medicare model was derived from a 2001 to 2004 population in the early emergence of endovascular aneurysm repair (EVAR) and did not account for any anatomic, laboratory, or medication factors. Therefore, we sought to develop a risk score calculator, driven from the most recent vascular-specific data, that incorporates all important operative mortality predictors, internally validate it, and compare it with the Medicare model.
(AAA) repair identified the shortcomings of the current risk calculators. Those were the sole reliance on the physiologic condition of the patient and lack of aneurysm-related predictors. For example, the Medicare model was derived from a 2001 to 2004 population in the early emergence of endovascular aneurysm repair (EVAR) and did not account for any anatomic, laboratory, or medication factors. Therefore, we sought to develop a risk score calculator, driven from the most recent vascular-specific data, that incorporates all important operative mortality predictors, internally validate it, and compare it with the Medicare model.
Methods: The Vascular Quality Initiative 2003 to 2017 database was used for open AAA repair (OAR) and EVAR procedures. Stepwise backward selection based on Akaike information criterion values was performed to identify the important predictors of operative mortality (death occurred before discharge or within 30 days) of OAR and EVAR. Bootstrap of 1000 reps was done to validate the model. C and Hosmer-Lemeshow statistics were examined to assess the model calibration and discrimination. The Medicare model was implemented on all Vascular Quality Initiative patients to check for its predictive ability and to compare it with actual mortality and with our new model.
Results .39]), and type of treatment (OAR vs EVAR, ). We then obtained the associated risk scores from the final validated model (Fig 1) . C statistic for the current model was slightly but significantly better than Medicare's (88% [87.5%-89.5%] vs 86.5% [85.3%-87.6%]; P < .001). Hosmer-Lemeshow statistic proved acceptable calibration (P ¼ .199). The observed mortality over the predicted probability of death derived from this model and Medicare's was plotted. Whereas both performed well in low-risk patients, the current model has better performance in the moderate and high probability of mortality (Fig 2) .
Conclusions: We presented in this study a risk calculator derived from contemporary vascular-specific data to help predict AAA repair mortality. Incorporating additional predictors pertinent to vascular patients, such as aortic diameter, creatinine and hemoglobin levels, medication use, and prior vascular interventions, improved the predictive ability of this calculator. This work will help surgeons and patients weigh the risk-benefit of treating AAA. Objective: Thirty-day mortality rates after open and endovascular intervention for aortic dissection remain high. Increased understanding of preoperative comorbidities and factors that increase the risk of mortality can help guide patient, family, and provider decision-making.
Methods: The American College of Surgeons National Surgical Quality Improvement Program database was queried for patients undergoing open and endovascular repair of thoracic and abdominal aortic dissections between 2010 and 2015. Information about patients' demographics, comorbidities, preoperative laboratory values, procedure details, and postoperative comorbidities was collected. Our goal was to determine features of the patients associated with 30-day mortality. SPSS (IBM Corp, Armonk, NY) was used to perform all univariate and multivariate analyses. We used Mann-Whitney and c 2 tests of significance for data analysis, and post hoc test was performed for power analysis.
Results: There were 411 patients who met the specified criteria, 364 who survived longer than 30 days postoperatively and 47 who died within 30 days of the intervention. Age, sex, and race were not significant determinants of survival after aortic dissection repair. In comparing those who survived beyond 30 days postoperatively and those who did not, preoperative ventilator dependence (odds ratio [OR] . 6.07; 95% confidence interval [CI], 1.8-19.9; P ¼ .001) and a history of chronic obstructive pulmonary disease (OR 3.01; 95% CI, 1.5-5.9; P ¼ .001) were predictive of mortality. Need for blood transfusion (OR, 5.92; 95% CI, 2.4-14.6; P ¼ .001) and emergent operation status (OR, 6.57; 95% CI, 3.4-12.5; P ¼ .001) were also predictive of 30-day mortality. Patients who did not survive 30 days postoperatively were more likely to have elevated preoperative blood urea nitrogen (P ¼ .001) and creatinine (P ¼ .001) levels and decreased hematocrit (P ¼ .003).
Conclusions: Multiple preoperative factors increase mortality risk after aortic dissection repair. The results of this study can help to optimize selection of patients and postoperative management, particularly in elective procedures.
Author Disclosures: M. J. Adair: Nothing to disclose; M. Baldawi: Nothing to disclose; C. Das: Nothing to disclose; B. M. Krafcik: Nothing to disclose; S. F. Markowiak: Nothing to disclose; M. Nazzal: Nothing to disclose. Primary outcomes were all-cause mortality and AAA-related mortality. Freedom from reintervention, presence of hydronephrosis (HF) caused by perianeurysmal fibrosis, and renal insufficiency (defined as absolute serum creatinine value >2 mg/dL or an increased value >0.5 mg/dL vs the baseline one) before and after repair at the last follow-up were considered secondary end points. EVAR was performed according to the instructions for use of each device.
Results: Mean follow-up was 30 (range, 0-156) months. There were 108 (92%) patients treated by OS; the remaining 9 (8%) were treated by EVAR. Mean sac diameter was 68 (614) mm. Twenty-one (18%) patients had a ruptured IAAA. The 30-day mortality was 5.9% (n ¼ 7), with all deaths occurring in the OS group (P ¼ .431). Overall survival was 70.4%, 59.3%, and 29.6% at 1 year, 2 years, and 5 years, respectively. Elective survival was 95.7%, 92.8%, and 79.3% at 1 year, 2 years, and 5 years (EVAR vs OS, P ¼ .45); 11 (9.5%) aneurysm-related deaths occurred, 2 in the EVAR group and 9 in the OS group (P ¼ .2). Freedom from reintervention was 93.9%, 91.6%, and 83.5% at 1 year, 2 years, and 5 years, respectively. Reintervention rate was more frequent in the EVAR vs the OS group (55.6% vs 4.6%; P < .001). HF occurred in 26 (22%) and 17 (14%) patients before and after repair, respectively. Repair resolved HF in 17 patients, whereas new HF occurred after repair in another 8 patients. Before repair, HF was similar between the OS and EVAR groups (14% vs11.1%; P ¼ .873), whereas it was more frequent in the EVAR group after repair (44.4% vs 12%; P ¼ .008). Renal insufficiency rate was similar before repair in the two groups (11% vs 6.5%; P ¼ .48), but it was more frequent after EVAR (33.3% vs 7.4%; P ¼ .01). Three patients underwent dialysis, all in the OS group. At multivariate analysis, independent predictors of mortality were OS (odds ratio [OR], 3.5; 95% confidence interval [CI],1.6-4.8; P ¼ .02), age >80 years (OR, 1.3; 95% CI, 1.1-1.6; P ¼ .001), urgent repair (OR, 34.9; 95% CI, 11.6-47.8; P ¼ .036), HF before repair (OR, 8.6; 95% CI, 1.3-56.3; P ¼ .025), and anticoagulation therapy (OR, 9.4; 95% CI, 2.6-14.8; P ¼ .036).
Conclusions: The mortality rate of IAAA is still high and associated with OS. EVAR could be a reasonable option to decrease the mortality rate in such complex patients. However, EVAR did not seem to offer any benefits for HF and renal insufficiency. More patients and long-term data are still needed.
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Methods: We studied all endovascular repairs of complex AAA (zone 6 or caudal) from 2012 to 2017 in the Vascular Quality Initiative. This included all fenestrated, branched, and snorkel/chimney repairs composed of off-the-shelf, custom-manufactured, and physician-modified devices.
Results: There were 1663 complex endovascular repairs; 1534 (92%) were performed electively, 83 (5%) were symptomatic, and 45 (3%) were ruptured. The average age was 74 (6 8) years; 22% were female, and 87% were white. There were 604 off-the-shelf fenestrated devices, 673 custom-manufactured grafts, 189 physician-modified devices, and 197 chimney/snorkels. There were 4958 renal-visceral vessels intervened on: 391 (24%) repairs involving two vessels, 646 (39%) three vessels, and 557 (33%) four vessels, with a median of three (interquartile range, two to four). The number of centers contributing complex repairs expanded from 2 centers in 2 regions in 2012 to 81 centers from 17 regions in 2017. The number of repairs increased steadily from 5 in 2012 to 525 in 2016. Eleven percent of patients had prior AAA repairs. The rate of perioperative death was 3.5% for elective cases, 6% for symptomatic, and 22% for ruptures, with no significant change over time and no difference based on repair type. The overall perioperative complication rate was 29%. By RIFLE (Risk, Injury, Failure, Loss of kidney function, and End-stage) criteria, 309 patients (19%) experienced acute kidney injury: risk, 98 (6%); injury, 76 (5%); failure, 85 (5%); loss of function (temporary dialysis), 21 (1.3%); endstage renal disease, 29 (2%). Twelve patients (0.7%) underwent open conversion during the index hospitalization. There were 46 (3%) patients with mesenteric ischemia, 19 of whom (1%) underwent bowel resections. Sixteen patients (1%) experienced strokes, 4 patients (0.2%) suffered transient ischemic attacks, and 60 patients (4%) had myocardial infarctions. There were 62 patients reintubated after the initial procedure (4%), and 109 patients (7%) had access site complications. During the index hospitalization, 75 patients (5%) underwent reinterventions related to their aneurysm, and 10 (1%) underwent unrelated operations. The 1-, 2-, and 3-year mortality rates were 91%, 89%, and 88%, respectively, with no significant difference by device type (P ¼ .30).
Conclusions: Complex endovascular repair is becoming increasingly common, both in the number of operations and in the number of centers and regions in which they occur. Rates of perioperative morbidity and mortality as well as 2-year survival are acceptable, but further study is needed to establish the durability of these novel technologies.
Author Disclosures: S. E. Deery: Nothing to disclose; M. F. Fillinger: Nothing to disclose; C. Li: Nothing to disclose; P. Liang: Nothing to disclose; T. F.X. O'Donnell: Nothing to disclose; V. I. Patel: Nothing to disclose; M. L. Schermerhorn: Abbott: Consulting fees (eg, advisory boards), Bolton: Consulting fees (eg, advisory boards), Cook: Consulting fees (eg, advisory boards), Endologix: Consulting fees (eg, advisory boards); N. J. Swerdlow: Nothing to disclose. Objective: The Cook Zenith fenestrated endovascular graft (ZFEN; Cook Medical, Bloomington, Ind) is the only commercially available graft in the United States. Fenestrated endograft technology has been widely accepted as a safe and effective technique to treat more complex abdominal aortic aneurysm anatomy. Data suggest that most centers do only a small volume of cases, despite widespread training of surgeons on the procedure. We reviewed the first 100 consecutive ZFEN endografts performed at our center to evaluate this technology.
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Outcomes of the
Methods: A prospectively maintained database of all aortic aneurysm repairs was queried for all fenestrated endovascular aneurysm repairs (FEVARs) performed since July 2013. Demographic data were obtained in addition to aortic anatomic characteristics, periprocedural details (radiation dose available after June 2015), and postoperative outcomes. Statistical analysis was performed with the SAS software package (SAS Institute, Cary, NC).
Results: There were 100 FEVARs performed from July 2013 to June 2017 (80% male; mean age, 73 6 8.1 years). Two surgeons performed 92% of cases. All cases were elective; 91 were performed for aneurysm disease (28% juxtarenal, 63% pararenal), and 9 were performed for type I endoleaks. There was a 98% aneurysm exclusion rate with 264 vessels cannulated through 272 fenestrations (97% technical success). Graft
